PRQRProQR Therapeutics N.V.

Nasdaq proqr.com


$ 1.95 $ -0.02 (-1.02 %)    

Friday, 26-Apr-2024 15:51:18 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.94
$ 1.96
$ 0.00 x 0
$ 0.00 x 0
$ 1.95 - $ 1.98
$ 1.11 - $ 3.29
50,793
na
157.83M
$ 1.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 proqr-therapeutics-says-it-achieved-successful-defense-of-new-challenge-to-its-axiomer-ip-portfolio

The company announced it has again successfully defended against opposition filed against a key patent for its ADAR-mediated RN...

 hc-wainwright--co-reiterates-buy-on-proqr-therapeutics-maintains-5-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates ProQR Therapeutics (NASDAQ:PRQR) with a Buy and maintains $5 price ta...

 chardan-capital-maintains-buy-on-proqr-therapeutics-raises-price-target-to-25

Chardan Capital analyst Keay Nakae maintains ProQR Therapeutics (NASDAQ:PRQR) with a Buy and raises the price target from $2...

 proqr-therapeutics-fy-eps-038-up-from-097-yoy

ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.38) per share. This is a 61.09 percent increase over losses o...

 proqr-highlights-new-platform-data-from-presentation-on-axiomer-rna-editing-technology-at-deaminet-2024

Platform demonstrates robust in vivo editing capabilities reporting up to 70% editing of ACTB in the liver of non-human prima...

 why-keycorp-shares-are-trading-lower-by-over-5-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results...

 why-airspan-networks-shares-are-trading-higher-by-over-380-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announ...

 us-stocks-lower-dow-falls-over-50-points

U.S. stocks traded lower this morning, with the Dow Jones index falling over 50 points on Monday. Following the market opening...

 bluebird-bio-to-rally-around-267-here-are-10-top-analyst-forecasts-for-wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 raymond-james-maintains-outperform-on-proqr-therapeutics-lowers-price-target-to-4

Raymond James analyst Steven Seedhouse maintains ProQR Therapeutics (NASDAQ:PRQR) with a Outperform and lowers the price tar...

 chardan-capital-upgrades-proqr-therapeutics-to-buy-announces-2-price-target

Chardan Capital analyst Keay Nakae upgrades ProQR Therapeutics (NASDAQ:PRQR) from Neutral to Buy and announces $2 price target.

 citigroup-maintains-buy-on-proqr-therapeutics-lowers-price-target-to-18

Citigroup analyst Yigal Nochomovitz maintains ProQR Therapeutics (NASDAQ:PRQR) with a Buy and lowers the price target from $...

 hc-wainwright--co-reiterates-buy-on-proqr-therapeutics-maintains-5-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates ProQR Therapeutics (NASDAQ:PRQR) with a Buy and maintains $5 price ta...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION